A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was whether following up patients after lobectomy for non-small cell lung cancer (NSCLC) with computed tomography (CT) scanning is of benefit in terms of survival. Altogether, 448 papers were found using the reported search, of which five represented the best evidence to answer the clinical question and three provided supporting evidence. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. There is no general consensus in the literature. From the limited number of papers that address the effect of CT follow-up on survival following surgery for NSCLC, three showed that CT scanning may improve the survival of patients by detecting local and distant recurrences at an earlier stage when the patient is asymptomatic. One paper showed that detection by the use of low-dose CT or simultaneous chest CT plus positron emission tomography-CT led to a longer duration of survival compared with detection by clinical suspicion (2.1 ± 0.3 vs 3.6 ± 0.2 years, p = 0.002). However, two papers broadly showed that follow-up with CT does not improve survival outcomes regardless of the site of recurrence. One such study showed that there was no clinically significant difference in survival whether patients were followed up using a strict CT protocol compared with a symptom-based follow-up (median survival after recurrence: strict 7.9 months, symptom-based 6.6 months, p = 0.219). The remaining papers supported the use of CT as a screening tool for recurrence but did not comment directly on survival. Owing to the limited and contradictory evidence, there is a need for an randomized controlled trial to assess the survival outcomes of patients followed up with a CT screening protocol vs a symptom-based follow-up.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION
In [ patients who have undergone lobectomy for non-small cell lung cancer (NSCLC)] will [follow-up computed tomography (CT) scanning] improve [survival rates]?
CLINICAL SCENARIO
You have under your care a 62-year old patient who had a lobectomy for NSCLC 12 months ago. He has been scheduled for a routine chest X-ray (CXR) to detect recurrence of the cancer. During the consultation, he mentions a friend of his with colorectal cancer being followed up by CT scan. He asks whether the X-ray is more likely to detect recurrence than CT scans of his chest, whether this may have survival benefit and which parts of his body might require CT. You resolve to check the literature yourself in order to help him make an informed decision. (PET)-CT. From the search, five papers were identified that provided evidence addressing the specific question. These are presented in Table 1 . Three papers provided supporting evidence, but did not directly assess survival outcomes and these are presented in Table 2 .
RESULTS
Westeel et al. [2] studied the feasibility of an intensive surveillance programme, which included six monthly CTs and their influence on patient survival. They found that the 35 asymptomatic recurrences found on scheduled visits had significantly better survival rates (3-year survival, 31%) than the 50 symptomatic recurrences (3-year survival, 10%). However, the asymptomatic group accounted for only 26% of the recurrences detected. Within this group, an equal number were picked up by bronchoscopy as with chest CT, and a higher number by physical examination or CXR. The majority of recurrences that could be treated with curative intent, however, were diagnosed by chest CT scan or bronchoscopy, rather than physical examination and chest radiography. They concluded that this more intensive policy of follow-up improved the survival outcome.
Lamont et al. [3] showed that follow-up of patients with surgically resected NSCLC, including annual CT, detects second primary lung cancer (SPLC) at an early stage (IA) that is potentially resectable. Fifteen percent of patients, all of whom were asymptomatic, were diagnosed with SPLC. Of these, 84% were detected at stage 1A. Fifty-eight percent were first picked up on CT scanning and 95% were potentially resectable. Although local recurrence of lung cancer (LRLC) can also be detected early, the prognosis for these patients is poor, and surgical treatment options are less likely to be affected by early detection. The median disease-free survival for patients with SPLC was significantly higher than that for patients with LRLC (P < 0.001).
Yokoi et al. [4] studied the detection of brain metastases after lung resection on an intensive CT follow-up regime. Of 128 patients prospectively followed up for a median time of 39 months postoperatively, they found that 60 patients had recurrence, of which 11 had brain metastasis. For these 11 patients, the median survival was 10 months with a 5-year survival rate of 24%. Seven of these 11 patients were neurologically asymptomatic at detection. For these seven asymptomatic patients, the median survival was 25 months with a higher 5-year survival of 38%. They concluded that intensive follow-up with CT facilitated early detection and effective treatment of brain metastases in patients with completely resected lung cancer.
Choi et al. [5] showed that using chest CT or PET-CT for the detection of recurrence improved the duration of survival compared with detection by clinical suspicion (3.6 ± 0.2 vs 2.1 ± 0.3 years, p = 0.002). PET-CT was better than chest CT alone for detecting recurrences of NSCLC. Of 51 recurrences detected by simultaneous PET-CT and chest CT, 19 were missed by conventional CT. However, because of the possibility of PET-CT failing to detect small or hypometabolic recurrences, they recommended that it be performed along with low-dose chest CT during annual surveillance. Despite this, there was no statistically significant difference in the duration of survival between detection with simultaneous PET-CT and chest CT (3.8 ± 0.2 years) vs detection with low-dose CT (3.3 ± 0.3 years, p = 0.179).
Younes et al. [6] compared the influence of strict routine follow-up, including CT scanning, after lung cancer resection on CT: computed tomography; CXR: chest X-ray; LDCT: low-dose computed tomography; NPV: negative predictive value; NSCLC: non-small cell lung cancer; PET-CT: positron emission tomography-computed tomography; PPV: positive predictive value; SDCT: standard-dose computed tomography.
the outcome of patients with NSCLC, with symptom-oriented follow-up. There was no clinically significant difference in median survival after recurrence ( p = 0.219). Chiu et al. [7] followed up 43 patients with a complete resection of NSCLC, which included low-dose CT every 3 months in the first 2 years post-operatively until tumour recurrence. Low-dose CT detected 79% of cases with tumour recurrence and 58% of all tumour recurrence sites. This study did not comment on survival.
Korst et al. [8] showed that surveillance CT is frequently abnormal post-resection but the majority of the abnormalities are not suspicious for recurrence. A retrospective analysis showed 105 abnormal CT findings in 92 patients 6 months or 1 year or yearly post-resection. Of these, 32 scans of 32 patients were suspicious for recurrence and further work-up showed recurrence or new malignancy in 16 of 32 patients. Of the 73 abnormal but unsuspicious scans, five patients had recurrence. Nine patients had interval lung cancers detected independently of surveillance CT scanning.
Korst et al. [9] then followed up the previously identified 92 patients for an average of 3.2 years. Of the 60 patients with the 73 abnormal but unsuspicious scans, 7 developed recurrent lung cancer during the follow-up period. Of the 16 patients with abnormal CT scans that were deemed suspicious but were found to have no further malignancy, 3 developed a recurrence during this follow-up period. The surgeon utilizing surveillance CT rarely missed recurrent NSCLC but a low-positive predictive value generated a significant number of negative and sometimes invasive investigations.
CLINICAL BOTTOM LINE
From the limited number of papers that address the effect of CT follow-up on survival following lobectomy for NSCLC, three [2, 4, 5] showed that CT scanning may improve the survival of patients by detecting local and distant recurrences at an earlier stage when the patient is asymptomatic, therefore allowing earlier interventions to take place. However, this may also require CT head in addition to CT chest [4] and we must also take into account lead-time bias when interpreting these results. Furthermore, it is important for doctors to explain the radiation implications of CT scanning to their patients.
Two papers [3, 6] broadly showed that follow-up with CT does not improve survival outcomes regardless of the site of recurrence. Owing to the limited and contradictory evidence, an randomized controlled trial to assess the survival outcomes of patients followed up with a CT screening protocol vs a symptom-based follow-up would be required to definitively comment on whether a survival benefit is present. The remaining papers [7] [8] [9] supported the use of CT as a screening tool for recurrence, although they did not directly comment on survival. It should be noted that ongoing studies are looking at the role of CT scanning in detecting lung cancers in high-risk individuals (current or former smokers) who have not had lung cancer. Two prominent trials [10, 11] have shown that CT screening for lung cancer increases the detection of early stage lung cancer but no reduction in mortality has been observed.
